Trial Profile
Evaluating Virological Effects of Abacavir/Lamivudine with Darunavir as compared to Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Oct 2016
Price :
$35
*
At a glance
- Drugs Lamivudine/abacavir (Primary) ; Darunavir; Ritonavir
- Indications HIV-1 infections
- Focus Therapeutic Use
- 01 Sep 2016 Results (n=676) published in the Clinical Drug Investigation
- 24 Dec 2015 New trial record